Great Britain Cosmetics Ingredient Changes in 2026: What Brands Need to Review
A focused summary of 2026 GB cosmetic ingredient restrictions, including 4-MBC and formaldehyde-releasing preservatives, with a practical portfolio-review approach.
This guide summarises EU or GB requirements as understood in October 2026. For product-specific decisions, the appointed Responsible Person and qualified specialists must review the actual dossier.
GB and EU annexes can move on different timetables
Great Britain's cosmetics legislation has developed separately from the EU framework since Brexit. A product assessed for one market should not simply be assumed to satisfy every current ingredient restriction in the other. Brands selling into both markets benefit from a controlled register of ingredient identities, concentrations, formula versions and applicable market status. This is especially important when a regulation includes a transitional sell-through provision.
Specific 2026 amendments
The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026 introduced GB changes effective on 15 July 2026 and 15 August 2026 for different provisions. They include prohibiting the UV filter 3-(4'-methylbenzylidene)-camphor (4-MBC), changing the warning-labelling threshold for certain formaldehyde-releasing preservatives and adding specified substances to the prohibited list following CMR classification. The statutory instrument sets out relevant transitional arrangements.
What to check in the product catalogue
Search formulation records using INCI names, CAS numbers and relevant supplier specifications. For affected ingredients, have a qualified reviewer assess the actual legal restriction, concentration, product type and dates. Then identify which labels, CPSRs, PIFs and commercial stock records need action. A product may be unaffected; a reformulation or revised warning may be needed for another. A generic list of 'banned ingredients' without dates and exceptions is not enough.
Avoid mixing up placing and making available
Regulatory transitions can distinguish placing a new product on the market from continuing to make earlier goods available. The UK 2026 instrument contains different transition dates for certain affected substances and labelling provisions. Teams should keep evidence of batch identities, distribution and placing dates when relying on a transitional rule, rather than making assumptions based purely on manufacture date.
Treat ingredient monitoring as an operations workflow
For each relevant legal change, record the affected products, reviewing specialist, legal date, required documents, artwork decision and implementation owner. Keep the final scientific and legal interpretation with qualified advisers. Varanos can support that administrative programme and the manufacturer requests, providing a clearer route from regulatory news to concrete catalogue action.
Official sources
Regulatory guidance evolves. Follow the links below to check for subsequent updates.
You build the brand.
We handle the path to market.
Tell us about your products and we can discuss a scoped document and specialist coordination project.
Discuss your products ↗